The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells

Liu, DL; Kaufmann, GF; Breitmeyer, JB; Dickson, KA; Marsh, DJ; Ford, CE

Ford, CE (通讯作者),Univ New South Wales, Fac Med & Hlth, Sch Clin Med, Gynaecol Canc Res Grp, Sydney, NSW 2052, Australia.

PHARMACEUTICS, 2022; 14 (4):

Abstract

The non-canonical Wnt signalling receptor ROR1 is aberrantly expressed in numerous cancers, including ovarian and endometrial cancer. We previously re......

Full Text Link